Compounds > l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide
Page last updated: 2024-09-02

l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and substance p (5-11), pglu(5)-mephe(8)-megly(9)-

l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide has been researched along with substance p (5-11), pglu(5)-mephe(8)-megly(9)- in 1 studies

Compound Research Comparison

Studies
(l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide)		Trials
(l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide)		Recent Studies (post-2010)
(l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide)		Studies
(substance p (5-11), pglu(5)-mephe(8)-megly(9)-)		Trials
(substance p (5-11), pglu(5)-mephe(8)-megly(9)-)		Recent Studies (post-2010) (substance p (5-11), pglu(5)-mephe(8)-megly(9)-)
138724700

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taché, Y; Yang, H1

Other Studies

1 other study(ies) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and substance p (5-11), pglu(5)-mephe(8)-megly(9)-

ArticleYear
Substance P in the dorsal vagal complex inhibits medullary TRH-induced gastric acid secretion in rats.
    The American journal of physiology, 1997, Volume: 272, Issue:5 Pt 1

    Topics: Animals; Biphenyl Compounds; Cerebral Ventricles; Gastric Acid; Kainic Acid; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Pyrrolidonecarboxylic Acid; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Solitary Nucleus; Substance P; Thyrotropin-Releasing Hormone; Vagus Nerve

1997